Stevens-Johnson syndrome associated with carvedilol therapy.
Stevens-Johnson syndrome, related to carvedilol use, has not been previously reported as a serious adverse experience requiring hospitalization. We report this reaction in a 71-year-old man with stable ischemic cardiomyopathy.
Kowalski
B J
BJ
Cardiology Division, The Ohio State University Medical Center, Columbus 43210, USA.
Cody
R J
RJ
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D000368:Aged; D002227:Carbazoles / Q000009:adverse effects* / Q000627:therapeutic use; D000077261:Carvedilol; D006801:Humans; D008297:Male; D017202:Myocardial Ischemia / Q000188:drug therapy; D011412:Propanolamines / Q000009:adverse effects* / Q000627:therapeutic use; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D014665:Vasodilator Agents / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D014665:Vasodilator Agents; D000077261:Carvedilol